3139 results for «237»

Filter By

3139 results

When multivessel disease is so complex

21 May 2025 – From EuroPCR 2025

Addressing the complexities of multivessel coronary disease, this session presents challenging cases including double chronic total occlusions and the emerging link between blood lipids and plaque formation. Learn strategic approaches to revascularization in NSTEMI and investigative insights into plaque biology.

When multivessel disease is so complex

How to optimise radiation exposure in the cathlab

21 May 2025 – From EuroPCR 2025

Explore comprehensive strategies to optimise radiation exposure in the cathlab through innovative technologies and workflow improvements. This session covers the implementation of radiation protection cabins, insights from the ROBO-SIL registry on robotic PCI, use of protective drapes, the EggNest system, exoskeleton-based radiation protection suits, and comparative...

How to optimise radiation exposure in the cathlab

A tale of two branches: lessons from complex bifurcation PCI

21 May 2025 – From EuroPCR 2025

Delve into complex bifurcation PCI with detailed case studies illustrating practical approaches to challenging scenarios, including managing stent loss in stented left main bifurcations. Gain valuable lessons from retrograde CTO-PCI and true bifurcation lesions to enhance your procedural strategies.

A tale of two branches: lessons from complex bifurcation PCI

Challenges in the treatment of patients with left main disease

21 May 2025 – From EuroPCR 2025

Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.

Challenges in the treatment of patients with left main disease

Academic Research Consortium on LAA closure

21 May 2025 – From EuroPCR 2025

Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.

Academic Research Consortium on LAA closure

Primary PCI for STEMI – Optimising outcomes

21 May 2025 – From EuroPCR 2025

Optimize primary PCI outcomes for STEMI patients by integrating state-of-the-art techniques and coronary physiology insights. The session includes case discussions highlighting treatment strategies and key learnings to enhance clinical practice.

Primary PCI for STEMI – Optimising outcomes

Novelties and future developments of sympathetic denervation to control blood pressure

21 May 2025 – From EuroPCR 2025

Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.

Novelties and future developments of sympathetic denervation to control blood pressure

DES and DCB for bifurcation treatment

21 May 2025 – From EuroPCR 2025

Examine the use of drug-eluting stents (DES) and drug-coated balloons (DCB) in bifurcation lesion treatment. This session compares devices, analyses DAPT duration, and evaluates side branch optimization to inform best practices in bifurcation PCI.

DES and DCB for bifurcation treatment

Non-antiplatelet drugs interventionalists should be aware of

21 May 2025 – From EuroPCR 2025

Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.

Non-antiplatelet drugs interventionalists should be aware of

Career and recognition for nurses and allied professionals in the cathlab: where are we?

21 May 2025 – From EuroPCR 2025

Explore the career landscape and recognition pathways for nurses and allied professionals in the cathlab. This session highlights workforce development, extraordinary career opportunities, and inspirational interviews to guide professional growth and empowerment.

Career and recognition for nurses and allied professionals in the cathlab: where are we?

Left main stenting techniques

21 May 2025 – From EuroPCR 2025

Examine advanced left main stenting techniques including DK crush and mini-crush strategies for complex bifurcation lesions. This session reviews stent malapposition in trifurcations, novel stent expansion outcomes, bifurcation angle correlations, and clinical results of double kissing crush versus culotte techniques.

Left main stenting techniques

New diagnostic and therapeutical tools in the coronary field

21 May 2025 – From EuroPCR 2025

Explore the latest advancements in diagnostic and therapeutic tools in coronary interventions. This session covers a range of innovative topics including the prognostic impact of QFR-based complete versus incomplete revascularisation, hybrid perfusion quantification with cardiac CT and echocardiography, clinical validation of AI-assisted coronary angiography, national audit...

New diagnostic and therapeutical tools in the coronary field

Unusual STEMI presentations: coronary embolism

21 May 2025 – From EuroPCR 2025

Investigate unusual STEMI presentations caused by coronary embolism through compelling case studies. Topics include differentiating thrombus from embolism, myocardial infarction after TAVI, paradoxical coronary embolism, septic emboli complications, and complex STEMI scenarios in TAVI patients.

Unusual STEMI presentations: coronary embolism

Acute and late coronary complications post-TAVI

21 May 2025 – From EuroPCR 2025

Gain insights into acute and late coronary complications following TAVI. This session discusses angina post-TAVI, mechanisms of acute severe mitral regurgitation during TAVR, hidden coronary obstructions, sudden hemodynamic collapse, and acute coronary occlusion after balloon aortic valvuloplasty.

Acute and late coronary complications post-TAVI

Novel tools and strategies in chronic heart failure

21 May 2025 – From EuroPCR 2025

Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...

Novel tools and strategies in chronic heart failure

Left ventricle assist device for very high-risk PCI

21 May 2025 – From EuroPCR 2025

Discover the role of left ventricle assist devices in very high-risk PCI cases. This session features complex interventions combining Impella support, advanced imaging, rotational atherectomy, bifurcation and CTO techniques, and fully percutaneous ECMO-assisted procedures under local anesthesia.

Left ventricle assist device for very high-risk PCI

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

04 Nov 2021

View this case with a 38-year-old male with effort angina and chronic total occlusion at the ostial segment of the left anterior descending artery.

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY
Didn’t find what you were looking for?